A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease (Q37465017)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease |
scientific article |
Statements
1 reference
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. (English)
1 reference
K Blennow
1 reference
S Salloway
1 reference
R Sperling
1 reference
S Gilman
1 reference
N C Fox
1 reference
M Raskind
1 reference
M Sabbagh
1 reference
L S Honig
1 reference
R Doody
1 reference
C H van Dyck
1 reference
R Mulnard
1 reference
J Barakos
1 reference
K M Gregg
1 reference
E Liu
1 reference
I Lieberburg
1 reference
D Schenk
1 reference
R Black
1 reference
M Grundman
1 reference
Bapineuzumab 201 Clinical Trial Investigators
1 reference
Identifiers
1 reference